Baseline demographics and clinical characteristics of the EORTC QLQ-C30 analysis set
| Characteristic . | Liso-cel (n = 47) . | SOC (n = 43) . | Overall (N = 90) . |
|---|---|---|---|
| Male sex, n (%) | 22 (46.8) | 28 (65.1) | 50 (55.6) |
| Age, y | |||
| Median (IQR) | 59 (53-67) | 56 (37-64) | 58 (43-66) |
| <65, n (%) | 32 (68.1) | 33 (76.7) | 65 (72.2) |
| ≥65 to <75, n (%) | 15 (31.9) | 10 (23.3) | 25 (27.8) |
| Baseline ECOG PS, n (%) | |||
| 0 | 21 (44.7) | 25 (58.1) | 46 (51.1) |
| 1 | 25 (53.2) | 18 (41.9) | 43 (47.8) |
| 2 | 1 (2.1) | 0 | 1 (1.1) |
| sAAIPI, n (%) | |||
| 0 or 1 | 27 (57.4) | 26 (60.5) | 53 (58.9) |
| 2 or 3 | 20 (42.6) | 17 (39.5) | 37 (41.1) |
| Prior response status, n (%) | |||
| Refractory | 37 (78.7) | 31 (72.1) | 68 (75.6) |
| Relapsed | 10 (21.3) | 12 (27.9) | 22 (24.4) |
| Median (IQR) time from initial diagnosis to randomization, mo | 7.0 (5.9-10.2) | 8.3 (5.9-11.4) | 7.4 (5.9-10.6) |
| Characteristic . | Liso-cel (n = 47) . | SOC (n = 43) . | Overall (N = 90) . |
|---|---|---|---|
| Male sex, n (%) | 22 (46.8) | 28 (65.1) | 50 (55.6) |
| Age, y | |||
| Median (IQR) | 59 (53-67) | 56 (37-64) | 58 (43-66) |
| <65, n (%) | 32 (68.1) | 33 (76.7) | 65 (72.2) |
| ≥65 to <75, n (%) | 15 (31.9) | 10 (23.3) | 25 (27.8) |
| Baseline ECOG PS, n (%) | |||
| 0 | 21 (44.7) | 25 (58.1) | 46 (51.1) |
| 1 | 25 (53.2) | 18 (41.9) | 43 (47.8) |
| 2 | 1 (2.1) | 0 | 1 (1.1) |
| sAAIPI, n (%) | |||
| 0 or 1 | 27 (57.4) | 26 (60.5) | 53 (58.9) |
| 2 or 3 | 20 (42.6) | 17 (39.5) | 37 (41.1) |
| Prior response status, n (%) | |||
| Refractory | 37 (78.7) | 31 (72.1) | 68 (75.6) |
| Relapsed | 10 (21.3) | 12 (27.9) | 22 (24.4) |
| Median (IQR) time from initial diagnosis to randomization, mo | 7.0 (5.9-10.2) | 8.3 (5.9-11.4) | 7.4 (5.9-10.6) |
IQR, interquartile range.